1.1 PEBC EE Blueprint, Format, Scoring, and IPG Certification Pathway

1.1 PEBC EE Blueprint, Format, Scoring, and IPG Certification Pathway

Exam Focus: The Pharmacy Examining Board of Canada (PEBC) Pharmacist Evaluating Examination assesses whether an International Pharmacy Graduate (IPG) possesses the foundational pharmaceutical knowledge, clinical problem-solving abilities, and professional competencies equivalent to a graduate of an accredited Canadian pharmacy degree program.

---

The Role and Mandate of the PEBC

The Pharmacy Examining Board of Canada (PEBC) is the national certification body for the pharmacy profession in Canada. It is a not-for-profit organization with more than 60 years of assessment experience, and its mandate is to assess qualifications and administer standardized examinations on behalf of the participating provincial pharmacy regulatory authorities.

In Canada, the constitutional responsibility for healthcare and professional regulation resides with provincial and territorial governments. Consequently, Provincial Pharmacy Regulatory Authorities (PRAs)—such as the Ontario College of Pharmacists (OCP), the College of Pharmacists of British Columbia (CPBC), and the Alberta College of Pharmacy (ACP)—hold exclusive statutory power to grant licenses within their respective jurisdictions. With the exception of Quebec (which maintains its own assessment process under the Ordre des pharmaciens du Québec), all Canadian PRAs require PEBC certification as a mandatory prerequisite for pharmacist licensure.

For International Pharmacy Graduates (IPGs), the Pharmacist Evaluating Examination (EE) serves as the initial academic gateway, validating that international undergraduate education meets Canadian standards before candidates are eligible to attempt the PEBC Pharmacist Qualifying Examination (Part I MCQ and Part II OSCE).

+-------------------------------------------------------------------------+
|                        IPG CERTIFICATION PATHWAY                        |
+-------------------------------------------------------------------------+
|  1. Document Evaluation & ECA (Degree Equivalence Verification)         |
|                                |                                        |
|                                v                                        |
|  2. Language Proficiency Verification (Provincial PRA Thresholds)       |
|                                |                                        |
|                                v                                        |
|  3. PEBC Evaluating Examination (140 MCQs / 3 Hours / Prometric)        |
|                                |                                        |
|                                v                                        |
|  4. PEBC Qualifying Examination (Part I MCQ & Part II OSCE)             |
|                                |                                        |
|                                v                                        |
|  5. Structured Practical Training / Bridging Programs (e.g., IPG)       |
|                                |                                        |
|                                v                                        |
|  6. Provincial Jurisprudence & Ethics Examination                       |
|                                |                                        |
|                                v                                        |
|  7. Full Licensure by Provincial Pharmacy Regulatory Authority (PRA)    |
+-------------------------------------------------------------------------+

---

Examination Structure and Prometric Administration

The PEBC Evaluating Examination is delivered as a computer-based test (CBT) through Prometric testing centres globally during designated testing windows. Candidates who cannot comply with test-centre procedures may instead schedule a remote-proctored sitting.

Core Structural Parameters

• Total Question Count: 140 multiple-choice questions (MCQs).
• Session Division: Administered in two separate 70-question sections.
• Testing Time: 90 minutes (1.5 hours) per section, providing a total examination writing time of 180 minutes (3 hours).
• Session Flow: PEBC schedules the exam as a single sitting of 3.25 hours, which covers the orientation to computer-based testing, the examination period itself, and a post-exam survey. Candidates are told to arrive 30 minutes before the appointment for the admission process. PEBC does not publish a scheduled mid-exam break, so plan to work through the sitting.
• Item Formats:
  • Independent MCQs: Standalone single-best-answer items. PEBC does not publish an option count for this exam, but every question in PEBC's official Evaluating Examination sample set uses five options (a–e), with one best answer in each case. Prepare for five options — a study product that drills only four-option items is training you on the wrong shape.
  • Short shared stems: A small number of items share a common set of patient information, with the paper indicating that two consecutive questions refer to the same scenario. The Evaluating Examination is predominantly a set of independent knowledge and application items rather than a long case-based paper; extended multi-question patient cases are a feature of the Qualifying Examination.
• Aids provided: The exam is closed book. An on-screen scientific calculator and a PEBC reference sheet of formulas are provided, so pharmacokinetic and clinical formulas do not need to be memorised. A dry erase board and markers are supplied at a test centre; remote-proctored candidates supply their own. No watches or timepieces are permitted, and the computer displays the time remaining.

---

The Revised June 2025 Blueprint

Effective June 2025, the PEBC implemented a revised blueprint for the Pharmacist Evaluating Examination. In previous iterations, the examination evaluated four separate domains, including a standalone "Biomedical Sciences" domain. The revised blueprint eliminated Biomedical Sciences as an independent section, embedding foundational anatomy, physiology, and pathology concepts directly into clinical application within the expanded Pharmacy Practice domain.

Domain Allocation and Question Weights

+-------------------------------------------------------------------------+
|            REVISED PEBC EE BLUEPRINT DOMAIN DISTRIBUTION (2025)         |
+-------------------------------------------------------------------------+
|                                                                         |
|   [============================] Pharmacy Practice (55% / ~77 MCQs)     |
|   [=============]                Pharmaceutical Sciences (25% / ~35 MCQs)|
|   [==========]                   BSA Pharmacy Sciences (20% / ~28 MCQs) |
|                                                                         |
+-------------------------------------------------------------------------+

Comprehensive Domain Breakdown

1. Pharmacy Practice (55% / Approximately 77 Questions)

This domain represents the largest component of the examination and tests the application of clinical knowledge, patient assessment, and therapeutic decision-making:

• Pathophysiology and Clinical Assessment: Interpreting subjective symptoms, physical examination findings, and clinical laboratory parameters (e.g., serum creatinine, electrolytes, liver function enzymes, lipid profiles, HbA1c, CBC, coagulation panels).
• Drug Therapy Problem (DTP) Management: Identifying, preventing, and resolving unnecessary drug therapy, untreated conditions, inappropriate drug selection, subtherapeutic or supratherapeutic dosages, adverse drug reactions, drug-drug and drug-food interactions, and non-adherence.
• Therapeutic Decision-Making: Developing, implementing, and monitoring evidence-based therapeutic regimens across major disease categories according to Canadian clinical practice guidelines (e.g., Hypertension Canada, Diabetes Canada, Canadian Cardiovascular Society, Canadian Thoracic Society).
• Minor Ailment Prescribing and Nonprescription Pharmacotherapy: Assessing self-limiting conditions, selecting Schedule II/III therapies, recommending non-pharmacological interventions, identifying red flags requiring medical referral, and applying provincial minor ailment prescribing algorithms.
• Special Populations: Individualizing pharmacotherapy for pediatric, geriatric (Beers Criteria, STOPP/START criteria, deprescribing), pregnant (teratogenicity, perinatal safety), lactating, renally impaired, and hepatically impaired patients.
• Prescription Dispensing and Calculations: Validating prescription authenticity, calculating pediatric and surface-area dosages, determining infusion rates, verifying drug product selection, and applying NAPRA compounding standards.

2. Pharmaceutical Sciences (25% / Approximately 35 Questions)

This domain evaluates the physicochemical, biological, and mechanistic foundations of drugs and delivery systems:

• Pharmaceutics and Drug Delivery: Physicochemical properties, solubility, ionization equilibria (pH/pKa, Henderson-Hasselbalch), dissolution kinetics (Noyes-Whitney equation), formulation design (modified-release, transdermal, aerosol, ophthalmic, parenteral), and degradation kinetics (hydrolysis, oxidation, photolysis).
• Biopharmaceutics and Pharmacokinetics: Absorption, distribution, metabolism (CYP450 isozymes, phase I/II pathways), and excretion (ADME); bioavailability ($F$) and bioequivalence; half-life ($t_{1/2}$), volume of distribution ($V_d$), clearance ($Cl$), steady-state dynamics ($C_{ss}$), and Therapeutic Drug Monitoring (TDM) for narrow-therapeutic-index drugs (e.g., aminoglycosides, vancomycin, phenytoin, digoxin, lithium).
• Pharmacology and Toxicology: Receptor pharmacology, signal transduction, mechanism of action, acute poisoning, toxidromes, overdose management, and clinical antidotes.
• Medicinal Chemistry and Pharmacogenomics: Structure-activity relationships (SAR), biologic therapies, biosimilars, and genetic polymorphisms affecting drug disposition and safety (e.g., CYP2D6, CYP2C19, TPMT, HLA-B*5701, DPYD).

3. Behavioural, Social, and Administrative (BSA) Pharmacy Sciences (20% / Approximately 28 Questions)

This domain encompasses healthcare systems, legal frameworks, ethics, and practice management:

• Canadian Healthcare Architecture and Legislation: Canada Health Act principles, federal drug regulation (Food and Drugs Act, Controlled Drugs and Substances Act), provincial pharmacy acts, and NAPRA Model Standards of Practice.
• Bioethics and Professionalism: Autonomy, beneficence, non-maleficence, justice, informed consent, patient confidentiality (PIPEDA/provincial health privacy acts), conflict of interest, and professional boundaries.
• Biostatistics and Critical Literature Appraisal: Study designs (randomized controlled trials, cohort, case-control), measures of association (relative risk, odds ratio, hazard ratio), absolute risk reduction (ARR), number needed to treat (NNT), number needed to harm (NNH), p-values, confidence intervals, and bias identification.
• Pharmacoepidemiology and Pharmacoeconomics: Cost-effectiveness analysis (CEA), cost-utility analysis (CUA, QALYs), incremental cost-effectiveness ratio (ICER), and Health Technology Assessment (CDA/CADTH).
• Medication Safety Systems: Incident reporting, root cause analysis (RCA), failure mode and effects analysis (FMEA), ISMP Canada error reduction strategies, continuous quality improvement (CQI), and cold-chain integrity.
• Health Equity and Indigenous Cultural Safety: Truth and Reconciliation Commission (TRC) Calls to Action, Jordan's Principle, social determinants of health, and culturally safe healthcare delivery for First Nations, Inuit, and Métis populations.

---

Scoring Methodology: Criterion-Referenced Standard

The PEBC Evaluating Examination uses a criterion-referenced model: performance is judged against an absolute standard of the knowledge expected of a Canadian entry-level graduate, not against the relative performance of the rest of the cohort. There is no built-in pass or failure rate and no curve.

Scoring Rules and Reporting Policies

1. The published standard. Unlike the Qualifying Examination, whose cut score varies with form difficulty, PEBC states the Evaluating Examination standard directly: "If you achieve at least 60% of the total possible score (140), you will be awarded pass standing." Each question is worth one mark, so the target is 84 correct answers out of 140. Use that number when you set practice targets — a 70% practice average carries real margin, a 62% average does not.
2. Pass/Fail designation. Despite the published percentage, candidates receive only a Pass or Fail result. PEBC does not release overall exam scores, passing scores, or question content, on the basis that score differences on a certification exam are not meaningful for the decision being made.
3. Feedback reports. For the Evaluating Examination, a feedback report is added to the Digital Wallet of every candidate alongside the results letter — not only unsuccessful candidates, which is the rule for the Qualifying Examination. The report gives relative performance across the three blueprint subject areas and should be read against the blueprint weightings, since 55% of the exam sits in Pharmacy Practice.
4. Results timing. Results are posted to the PEBC website up to five weeks after the exam, and the individual results letter is added to the Digital Wallet within one week of that posting. Results are never released by telephone.
5. Attempt limits. Candidates are permitted three attempts. After three unsuccessful attempts the Board will consider a petition for a fourth and final attempt on evidence, acceptable to the Board, of remediation completed to its specifications; that documentation goes to PEBC, not to a provincial regulatory authority. A candidate who fails a fourth attempt cannot register for the Evaluating Examination again.
6. Re-scoring. An unsuccessful candidate may request one hand scoring, which confirms data entry and tabulation only. The request and fee must reach PEBC within 75 days of the release of results. The content, methodology, and standards of the exam are not subject to appeal.

---

The 2026-2027 Pathway Transition: Final Sitting of the EE

The Canadian licensing framework for international pharmacy graduates is undergoing a major structural evolution:

• Final Sitting in October 2026: The October 2026 examination represents the final scheduled sitting of the PEBC Pharmacist Evaluating Examination.
• The 2027 Direct-Entry Model: Beginning in 2027, the certification pathway will transition to allow eligible IPGs who have successfully completed PEBC Document Evaluation to enter directly into the PEBC Qualifying Examination (Part I MCQ) alongside comprehensive bridging and workplace integration programs.

---

Prerequisite Steps: Document Evaluation and Language Proficiency

Before an IPG can schedule the Evaluating Examination, two foundational requirements must be completed:

1. Document Evaluation and Educational Credential Assessment (ECA)

• Academic Verification: PEBC reviews official university transcripts, syllabi, and proof of graduation to verify completion of a minimum 4-year undergraduate pharmacy degree program comparable to Canadian academic standards.
• Licensing Standing: Verification of licensure or good standing from the regulatory authority in the candidate's jurisdiction of education or prior practice.
• ECA for Immigration: For candidates applying for Canadian permanent residency through Express Entry or Provincial Nominee Programs (PNP), PEBC is the designated professional body authorized by Immigration, Refugees and Citizenship Canada (IRCC) to issue pharmacist ECA reports.

2. Language Proficiency Standards

This is the step candidates most often misunderstand. PEBC itself has no language fluency requirement and does not set a minimum test score for any of its examinations. Language proficiency is a licensure requirement set independently by each provincial or territorial regulatory authority, and the accepted tests and minimum scores differ between jurisdictions.

What this means in practice:

• You may sit the Evaluating Examination without having completed a language test.
• The accepted instruments are typically the academic IELTS, TOEFL iBT, CELPIP, or the pharmacy version of the Occupational English Test, but the required overall and sub-test scores, and the period for which a result stays valid, are set province by province.
• Verify the current requirement directly with the regulatory authority in the province where you intend to be licensed, before you pay for a test.

PEBC does caution that language proficiency materially affects performance on both the Evaluating Examination and the Qualifying Examination, and that effective written and verbal communication at a level appropriate to a health professional is essential — particularly for the Part II OSCE.